Cedrol ameliorates ulcerative colitis via myeloid differentiation factor 2-mediated inflammation suppression, with barrier restoration and microbiota modulation

Figure 1 Cedrol ameliorated dextran sulfate sodium-induced colitis symptoms. A: Chemical structure of cedrol; B: Experimental scheme diagram; C: Body weight changes during the experimental period; D: Representative colons from each group; E: Quantitative analysis of colon length; F: Disease activity index scores. Data are expressed as mean ± SD (n = 6). ^bP < 0.01. ^cP < 0.001. CE: Cedrol; DSS: Dextran sulfate sodium; i.g.: Gavage; DAI: Disease activity index.